|
24 Jul 2020 |
Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
|
|
23 Jul 2020 |
G1 Therapeutics Announces License Agreement for Lerociclib
|
|
22 Jul 2020 |
Qualigen Therapeutics Signs Exclusive License Agreement with the University of Louisville for RAS Interaction Inhibitor Drug Candidates
|
|
21 Jul 2020 |
UNION therapeutics announces acquisition of PDE4i compound class from LEO Pharma with oral lead candidate (orismilast) in Phase 2
|
|
21 Jul 2020 |
Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million
|
|
21 Jul 2020 |
Jnana Therapeutics Enters Collaboration with Roche to Discover Novel Medicines that Target Key Regulators of Cellular Metabolism to Treat Immune-Mediated and Neurological Diseases
|
|
21 Jul 2020 |
Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates
|
|
18 Jul 2020 |
Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals
|
|
14 Jul 2020 |
Sanofi And MD Anderson Announce Strategic Collaboration To Accelerate Oncology Research And Development
|
|
14 Jul 2020 |
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers
|
|
13 Jul 2020 |
Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV
|
|
09 Jul 2020 |
Zymeworks Announces New Multispecific Antibody Collaboration with Merck
|
|
09 Jul 2020 |
ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics
|
|
09 Jul 2020 |
Foghorn® Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target
|
|
07 Jul 2020 |
Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
|
|
07 Jul 2020 |
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
|
|
06 Jul 2020 |
Dragonfly Therapeutics Announces New Research Collaboration with Bristol Myers Squibb to Develop Novel Therapeutic Candidates for Multiple Sclerosis and Neuro-inflammation Target
|
|
02 Jul 2020 |
Merck and Ridgeback Bio Announce Closing of Collaboration and Licensing Transaction
|
|
01 Jul 2020 |
Aligos Therapeutics and KU Leuven Announce Collaboration for the Development of a Therapeutic Candidate Targeting Coronavirus
|
|
01 Jul 2020 |
Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular Vesicles Platform
|
|
30 Jun 2020 |
Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance
|
|
29 Jun 2020 |
VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical
|
|
26 Jun 2020 |
Sosei Heptares and AbbVie Announce New Discovery Collaboration Targeting Inflammatory Diseases
|
|
24 Jun 2020 |
Yumanity Therapeutics Announces Strategic Research Collaboration and License Agreement with Merck Focused on Accelerating the Development of New Treatments for Neurodegenerative Diseases
|
|
24 Jun 2020 |
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
|
